{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:18:08Z","timestamp":1792016288658,"version":"4.4.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["FG 27"],"award-info":[{"award-number":["FG 27"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuroimaging plays a crucial role in diagnosing multiple system atrophy and monitoring progressive neurodegeneration in this fatal disease. Advanced MRI techniques and post-processing methods have demonstrated significant volume loss and microstructural changes in brain regions well known to be affected by MSA pathology. These observations can be exploited to support the differential diagnosis of MSA distinguishing it from Parkinson's disease and progressive supranuclear palsy with high sensitivity and specificity. Longitudinal studies reveal aggressive neurodegeneration in MSA, with notable atrophy rates in the cerebellum, pons, and putamen. Radiotracer imaging using PET and SPECT has shown characteristic disease-related patterns, aiding in differential diagnosis and tracking disease progression. Future research should focus on early diagnosis, particularly in prodromal stages, and the development of reliable biomarkers for clinical trials. Combining different neuroimaging modalities and machine learning algorithms can enhance diagnostic precision and provide a comprehensive understanding of MSA pathology.<\/jats:p>","DOI":"10.1007\/s00702-025-02964-6","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T10:38:30Z","timestamp":1752316710000},"page":"875-889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of neuro-imaging in multiple system atrophy"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-5073","authenticated-orcid":false,"given":"Florian","family":"Krismer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-1455","authenticated-orcid":false,"given":"Klaus","family":"Seppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4367-0971","authenticated-orcid":false,"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"2964_CR1","doi-asserted-by":"publisher","first-page":"16488","DOI":"10.1038\/s41598-019-52829-8","volume":"9","author":"A Abos","year":"2019","unstructured":"Abos A, Baggio HC, Segura B et al (2019) Differentiation of multiple system atrophy from Parkinson\u2019s disease by structural connectivity derived from probabilistic tractography. Sci Rep 9:16488. https:\/\/doi.org\/10.1038\/s41598-019-52829-8","journal-title":"Sci Rep"},{"key":"2964_CR2","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1016\/s2589-7500(19)30105-0","volume":"1","author":"DB Archer","year":"2019","unstructured":"Archer DB, Bricker JT, Chu WT et al (2019) Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study. Lancet Digit Health 1:e222\u2013e231. https:\/\/doi.org\/10.1016\/s2589-7500(19)30105-0","journal-title":"Lancet Digit Health"},{"key":"2964_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3389\/fneur.2020.00791","volume":"11","author":"G Arribarat","year":"2020","unstructured":"Arribarat G, Barros AD, P\u00e9ran P (2020) Modern brainstem MRI techniques for the diagnosis of Parkinson\u2019s disease and Parkinsonisms. Front Neurol 11:791. https:\/\/doi.org\/10.3389\/fneur.2020.00791","journal-title":"Front Neurol"},{"key":"2964_CR4","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/hbm.23481","volume":"38","author":"M Arshad","year":"2017","unstructured":"Arshad M, Stanley JA, Raz N (2017) Test\u2013retest reliability and concurrent validity of in vivo myelin content indices: myelin water fraction and calibrated T1w\/T2w image ratio. Hum Brain Mapp 38:1780\u20131790. https:\/\/doi.org\/10.1002\/hbm.23481","journal-title":"Hum Brain Mapp"},{"key":"2964_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189897","volume":"12","author":"S Bajaj","year":"2017","unstructured":"Bajaj S, Krismer F, Palma J-A et al (2017) Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: a systematic review and meta-analysis. PLoS ONE 12:e0189897. https:\/\/doi.org\/10.1371\/journal.pone.0189897","journal-title":"PLoS ONE"},{"key":"2964_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jnnp.2004.049221","volume":"76","author":"S Behnke","year":"2005","unstructured":"Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of Parkinson\u2019s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76:423\u2013425. https:\/\/doi.org\/10.1136\/jnnp.2004.049221","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2964_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2021.02.027","volume":"85","author":"V Beliveau","year":"2021","unstructured":"Beliveau V, Krismer F, Skalla E et al (2021) Characterization and diagnostic potential of diffusion tractography in multiple system atrophy. Parkinsonism Relat Disord 85:30\u201336. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.02.027","journal-title":"Parkinsonism Relat Disord"},{"key":"2964_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000314494","volume":"7","author":"D Berg","year":"2010","unstructured":"Berg D, Gaenslen A (2010) Place value of transcranial sonography in early diagnosis of Parkinson\u2019s disease. Neurodegener Dis 7:291\u2013299. https:\/\/doi.org\/10.1159\/000314494","journal-title":"Neurodegener Dis"},{"key":"2964_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00415-006-0325-6","volume":"254","author":"C Brenneis","year":"2007","unstructured":"Brenneis C, Egger K, Scherfler C et al (2007) Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study. J Neurol 254:191\u2013196. https:\/\/doi.org\/10.1007\/s00415-006-0325-6","journal-title":"J Neurol"},{"key":"2964_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/mds.22413","volume":"24","author":"DJ Brooks","year":"2009","unstructured":"Brooks DJ, Seppi K, MSA NWG on (2009) Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Movement Disord 24:949\u2013964. https:\/\/doi.org\/10.1002\/mds.22413","journal-title":"Movement Disord"},{"key":"2964_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.irn.2018.08.006","volume":"142","author":"J Brumberg","year":"2018","unstructured":"Brumberg J, Isaias IU (2018) Chapter two SPECT molecular imaging in atypical parkinsonism. Int Rev Neurobiol 142:37\u201365. https:\/\/doi.org\/10.1016\/bs.irn.2018.08.006","journal-title":"Int Rev Neurobiol"},{"key":"2964_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41531-020-00141-y","volume":"6","author":"J Brumberg","year":"2020","unstructured":"Brumberg J, Schr\u00f6ter N, Blazhenets G et al (2020) Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy. Npj Park\u2019s Dis 6:39. https:\/\/doi.org\/10.1038\/s41531-020-00141-y","journal-title":"Npj Park\u2019s Dis"},{"key":"2964_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mdc3.13227","volume":"8","author":"M Catalan","year":"2021","unstructured":"Catalan M, Dore F, Polverino P et al (2021) 123I-metaiodobenzylguanidine myocardial scintigraphy in discriminating degenerative Parkinsonisms. Mov Disord Clin Pract 8:717\u2013724. https:\/\/doi.org\/10.1002\/mdc3.13227","journal-title":"Mov Disord Clin Pract"},{"key":"2964_CR14","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/hbm.26201","volume":"44","author":"B Chen","year":"2023","unstructured":"Chen B, Cui W, Wang S et al (2023a) Functional connectome automatically differentiates multiple system atrophy (parkinsonian type) from idiopathic Parkinson\u2019s disease at early stages. Hum Brain Mapp 44:2176\u20132190. https:\/\/doi.org\/10.1002\/hbm.26201","journal-title":"Hum Brain Mapp"},{"key":"2964_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.110735","volume":"161","author":"B Chen","year":"2023","unstructured":"Chen B, He J, Xu M et al (2023b) Automatic classification of MSA subtypes using whole-brain gray matter function and structure-based radiomics approach. Eur J Radiol 161:110735. https:\/\/doi.org\/10.1016\/j.ejrad.2023.110735","journal-title":"Eur J Radiol"},{"key":"2964_CR16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/wco.0000000000000957","volume":"34","author":"L Chougar","year":"2021","unstructured":"Chougar L, Pyatigorskaya N, Leh\u00e9ricy S (2021) Update on neuroimaging for categorization of Parkinson\u2019s disease and atypical parkinsonism. Curr Opin Neurol 34:514\u2013524. https:\/\/doi.org\/10.1097\/wco.0000000000000957","journal-title":"Curr Opin Neurol"},{"key":"2964_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28988","author":"L Chougar","year":"2022","unstructured":"Chougar L, Arsovic E, Gaurav R et al (2022) Regional selectivity of neuromelanin changes in the substantia nigra in atypical Parkinsonism. Mov Disord. https:\/\/doi.org\/10.1002\/mds.28988","journal-title":"Mov Disord"},{"key":"2964_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105287","volume":"108","author":"L Chougar","year":"2023","unstructured":"Chougar L, Lejeune F-X, Faouzi J et al (2023) Comparison of mean diffusivity, R2* relaxation rate and morphometric biomarkers for the clinical differentiation of parkinsonism. Parkinsonism Relat Disord 108:105287. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105287","journal-title":"Parkinsonism Relat Disord"},{"key":"2964_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/mds.29760","volume":"39","author":"L Chougar","year":"2024","unstructured":"Chougar L, Faucher A, Faouzi J et al (2024) Contribution of MRI for the early diagnosis of parkinsonism in patients with diagnostic uncertainty. Mov Disord 39:825\u2013835. https:\/\/doi.org\/10.1002\/mds.29760","journal-title":"Mov Disord"},{"key":"2964_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/mds.22732","volume":"25","author":"R Dodel","year":"2010","unstructured":"Dodel R, Spottke A, Gerhard A et al (2010) Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial). Movement Disord 25:97\u2013107. https:\/\/doi.org\/10.1002\/mds.22732","journal-title":"Movement Disord"},{"key":"2964_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106828","volume":"206","author":"L Dong","year":"2025","unstructured":"Dong L, Zhou R, Zhou J et al (2025) Positron emission tomography molecular imaging for pathological visualization in multiple system atrophy. Neurobiol Dis 206:106828. https:\/\/doi.org\/10.1016\/j.nbd.2025.106828","journal-title":"Neurobiol Dis"},{"key":"2964_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.parkreldis.2021.07.025","volume":"90","author":"J Ebina","year":"2021","unstructured":"Ebina J, Hara K, Watanabe H et al (2021) Individual voxel-based morphometry adjusting covariates in multiple system atrophy. Parkinsonism Relat Disord 90:114\u2013119. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.07.025","journal-title":"Parkinsonism Relat Disord"},{"key":"2964_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-022-00853-6","author":"C Eckhardt","year":"2022","unstructured":"Eckhardt C, Krismer F, Donnemiller E et al (2022) Cardiac sympathetic innervation in Parkinson\u2019s disease versus multiple system atrophy. Clin Auton Res. https:\/\/doi.org\/10.1007\/s10286-022-00853-6","journal-title":"Clin Auton Res"},{"key":"2964_CR24","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.neuron.2024.05.006","volume":"112","author":"H Endo","year":"2024","unstructured":"Endo H, Ono M, Takado Y et al (2024) Imaging \u03b1-synuclein pathologies in animal models and patients with Parkinson\u2019s and related diseases. Neuron 112:2540-2557.e8. https:\/\/doi.org\/10.1016\/j.neuron.2024.05.006","journal-title":"Neuron"},{"key":"2964_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/mds.27987","volume":"35","author":"J Faber","year":"2020","unstructured":"Faber J, Giordano I, Jiang X et al (2020) Prominent white matter involvement in multiple system atrophy of cerebellar type. Mov Disord 35:816\u2013824. https:\/\/doi.org\/10.1002\/mds.27987","journal-title":"Mov Disord"},{"key":"2964_CR26","unstructured":"Fanciulli A, Stankovic I, Krismer F, et al (2019) Chapter Five Multiple system atrophy"},{"key":"2964_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00415-015-7934-x","volume":"263","author":"Y Fukui","year":"2016","unstructured":"Fukui Y, Hishikawa N, Sato K et al (2016) Characteristic diffusion tensor tractography in multiple system atrophy with predominant cerebellar ataxia and cortical cerebellar atrophy. J Neurol 263:61\u201367. https:\/\/doi.org\/10.1007\/s00415-015-7934-x","journal-title":"J Neurol"},{"key":"2964_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/jnnp-2016-314956","volume":"88","author":"SA Glasmacher","year":"2017","unstructured":"Glasmacher SA, Leigh PN, Saha RA (2017) Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 88:402. https:\/\/doi.org\/10.1136\/jnnp-2016-314956","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2964_CR29","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1523\/jneurosci.2180-11.2011","volume":"31","author":"MF Glasser","year":"2011","unstructured":"Glasser MF, Essen DCV (2011) Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci 31:11597\u201311616. https:\/\/doi.org\/10.1523\/jneurosci.2180-11.2011","journal-title":"J Neurosci"},{"key":"2964_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10286-018-0547-6","volume":"28","author":"DS Goldstein","year":"2018","unstructured":"Goldstein DS, Cheshire WP (2018) Roles of cardiac sympathetic neuroimaging in autonomic medicine. Clin Auton Res 28:397\u2013410. https:\/\/doi.org\/10.1007\/s10286-018-0547-6","journal-title":"Clin Auton Res"},{"key":"2964_CR31","doi-asserted-by":"publisher","first-page":"8640","DOI":"10.1038\/s41598-025-93520-5","volume":"15","author":"R Goto","year":"2025","unstructured":"Goto R, Matsuoka K, Kimura Y et al (2025) Human biodistribution and radiation dosimetry of two novel \u03b1-synuclein PET tracers, 18F-SPAL-T-06 and 18F\u2013C05-05. Sci Rep 15:8640. https:\/\/doi.org\/10.1038\/s41598-025-93520-5","journal-title":"Sci Rep"},{"key":"2964_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.irn.2018.08.010","volume":"142","author":"B Heim","year":"2018","unstructured":"Heim B, Krismer F, Seppi K (2018) Chapter Three Structural Imaging in Atypical Parkinsonism. Int Rev Neurobiol 142:67\u2013148. https:\/\/doi.org\/10.1016\/bs.irn.2018.08.010","journal-title":"Int Rev Neurobiol"},{"key":"2964_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D et al (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23:191\u2013204. https:\/\/doi.org\/10.1016\/s1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"key":"2964_CR34","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/s1474-4422(10)70216-7","volume":"9","author":"A Iranzo","year":"2010","unstructured":"Iranzo A, Lome\u00f1a F, Stockner H et al (2010) Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol 9:1070\u20131077. https:\/\/doi.org\/10.1016\/s1474-4422(10)70216-7","journal-title":"Lancet Neurol"},{"key":"2964_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.28814","volume":"37","author":"A Jucaite","year":"2022","unstructured":"Jucaite A, Csel\u00e9nyi Z, Kreisl WC et al (2022) Glia imaging differentiates multiple system atrophy from Parkinson\u2019s disease: a positron emission tomography study with [11C]PBR28 and machine learning analysis. Mov Disord 37:119\u2013129. https:\/\/doi.org\/10.1002\/mds.28814","journal-title":"Mov Disord"},{"key":"2964_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/mdc3.13987","volume":"11","author":"K Kawabata","year":"2024","unstructured":"Kawabata K, Krismer F, Heim B et al (2024) A blinded evaluation of brain morphometry for differential diagnosis of atypical Parkinsonism. Mov Disord Clin Pract 11:381\u2013390. https:\/\/doi.org\/10.1002\/mdc3.13987","journal-title":"Mov Disord Clin Pract"},{"key":"2964_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30182","author":"K Kawabata","year":"2025","unstructured":"Kawabata K, Krismer F, Ito M et al (2025) Trajectories of Pontine Volume in Patients with Multiple System Atrophy. Mov Disord. https:\/\/doi.org\/10.1002\/mds.30182","journal-title":"Mov Disord"},{"key":"2964_CR38","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/mds.21614","volume":"22","author":"M K\u00f6llensperger","year":"2007","unstructured":"K\u00f6llensperger M, Seppi K, Liener C et al (2007) Diffusion weighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 22:1771\u20131776. https:\/\/doi.org\/10.1002\/mds.21614","journal-title":"Mov Disord"},{"key":"2964_CR39","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/mds.27669","volume":"34","author":"F Krismer","year":"2019","unstructured":"Krismer F, Seppi K, G\u00f6bel G et al (2019) Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis. Mov Disord 34:1041\u20131048. https:\/\/doi.org\/10.1002\/mds.27669","journal-title":"Mov Disord"},{"key":"2964_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/mds.28281","volume":"36","author":"F Krismer","year":"2021","unstructured":"Krismer F, Beliveau V, Seppi K et al (2021) Automated analysis of diffusion-weighted magnetic resonance imaging for the differential diagnosis of multiple system atrophy from Parkinson\u2019s disease. Mov Disord 36:241\u2013245. https:\/\/doi.org\/10.1002\/mds.28281","journal-title":"Mov Disord"},{"key":"2964_CR41","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/s1474-4422(24)00396-x","volume":"23","author":"F Krismer","year":"2024","unstructured":"Krismer F, Fanciulli A, Meissner WG et al (2024a) Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment. Lancet Neurol 23:1252\u20131266. https:\/\/doi.org\/10.1016\/s1474-4422(24)00396-x","journal-title":"Lancet Neurol"},{"key":"2964_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.29633","volume":"39","author":"F Krismer","year":"2024","unstructured":"Krismer F, P\u00e9ran P, Beliveau V et al (2024b) Progressive brain atrophy in multiple system atrophy: a longitudinal, multicenter, magnetic resonance imaging study. Mov Disord 39:119\u2013129. https:\/\/doi.org\/10.1002\/mds.29633","journal-title":"Mov Disord"},{"key":"2964_CR43","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/mds.27620","volume":"34","author":"D K\u00fcbler","year":"2019","unstructured":"K\u00fcbler D, W\u00e4chter T, Cabanel N et al (2019) Widespread microglial activation in multiple system atrophy. Mov Disord 34:564\u2013568. https:\/\/doi.org\/10.1002\/mds.27620","journal-title":"Mov Disord"},{"key":"2964_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102989","volume":"34","author":"M Lancione","year":"2022","unstructured":"Lancione M, Cencini M, Costagli M et al (2022) Diagnostic accuracy of quantitative susceptibility mapping in multiple system atrophy: the impact of echo time and the potential of histogram analysis. Neuroimage Clin 34:102989. https:\/\/doi.org\/10.1016\/j.nicl.2022.102989","journal-title":"Neuroimage Clin"},{"key":"2964_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fneur.2019.00074","volume":"10","author":"J-H Lee","year":"2019","unstructured":"Lee J-H, Lee M-S (2019) Brain iron accumulation in atypical Parkinsonian syndromes: in vivo MRI evidences for distinctive patterns. Front Neurol 10:74. https:\/\/doi.org\/10.3389\/fneur.2019.00074","journal-title":"Front Neurol"},{"key":"2964_CR46","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00415-015-7785-5","volume":"262","author":"J-H Lee","year":"2015","unstructured":"Lee J-H, Kim T-H, Mun C-W et al (2015) Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes. J Neurol 262:1876\u20131882. https:\/\/doi.org\/10.1007\/s00415-015-7785-5","journal-title":"J Neurol"},{"key":"2964_CR47","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/s1474-4422(19)30141-3","volume":"18","author":"J Levin","year":"2019","unstructured":"Levin J, Maa\u00df S, Schuberth M et al (2019) Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 18:724\u2013735. https:\/\/doi.org\/10.1016\/s1474-4422(19)30141-3","journal-title":"Lancet Neurol"},{"key":"2964_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s11682-025-00984-0","author":"X Li","year":"2025","unstructured":"Li X, Pang H, Bu S et al (2025) Differentiating patterns of neuro-circuitry abnormalities in tremor dominant Parkinson\u2019s disease and multiple system atrophy: a resting-state fMRI study. Brain Imaging Behav. https:\/\/doi.org\/10.1007\/s11682-025-00984-0","journal-title":"Brain Imaging Behav"},{"key":"2964_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/s1474-4422(13)70301-6","volume":"13","author":"PA Low","year":"2014","unstructured":"Low PA, Robertson D, Gilman S et al (2014) Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 13:268\u2013275. https:\/\/doi.org\/10.1016\/s1474-4422(13)70301-6","journal-title":"Lancet Neurol"},{"key":"2964_CR50","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/s1474-4422(15)00058-7","volume":"14","author":"PA Low","year":"2015","unstructured":"Low PA, Reich SG, Jankovic J et al (2015) Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 14:710\u2013719. https:\/\/doi.org\/10.1016\/s1474-4422(15)00058-7","journal-title":"Lancet Neurol"},{"key":"2964_CR51","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/jmri.28693","volume":"58","author":"H Lyu","year":"2023","unstructured":"Lyu H, Zhu X, He N et al (2023) Alterations in resting-state MR functional connectivity of the central autonomic network in multiple system atrophy and relationship with disease severity. J Magn Reson Imaging 58:1472\u20131487. https:\/\/doi.org\/10.1002\/jmri.28693","journal-title":"J Magn Reson Imaging"},{"key":"2964_CR52","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/mds.29186","volume":"37","author":"K Matsuoka","year":"2022","unstructured":"Matsuoka K, Ono M, Takado Y et al (2022) High-contrast imaging of \u03b1-synuclein pathologies in living patients with multiple system atrophy. Mov Disord 37:2159\u20132161. https:\/\/doi.org\/10.1002\/mds.29186","journal-title":"Mov Disord"},{"key":"2964_CR53","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","volume":"58","author":"PT Meyer","year":"2017","unstructured":"Meyer PT, Frings L, R\u00fccker G, Hellwig S (2017) 18F-FDG PET in Parkinsonism: differential diagnosis and evaluation of cognitive impairment. J Nucl Med 58:1888\u20131898. https:\/\/doi.org\/10.2967\/jnumed.116.186403","journal-title":"J Nucl Med"},{"key":"2964_CR54","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/brain\/awz189","volume":"142","author":"Y Miki","year":"2019","unstructured":"Miki Y, Foti SC, Asi YT et al (2019) Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain 142:2813\u20132827. https:\/\/doi.org\/10.1093\/brain\/awz189","journal-title":"Brain"},{"key":"2964_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101858","volume":"23","author":"F Nemmi","year":"2019","unstructured":"Nemmi F, Traon AP-L, Phillips OR et al (2019) A totally data-driven whole-brain multimodal pipeline for the discrimination of Parkinson\u2019s disease, multiple system atrophy and healthy control. Neuroimage Clin 23:101858. https:\/\/doi.org\/10.1016\/j.nicl.2019.101858","journal-title":"Neuroimage Clin"},{"key":"2964_CR56","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mds.29309","volume":"38","author":"A Nobileau","year":"2023","unstructured":"Nobileau A, Gaurav R, Chougar L et al (2023) Neuromelanin-sensitive magnetic resonance imaging changes in the locus coeruleus\/subcoeruleus complex in patients with typical and atypical Parkinsonism. Mov Disord 38:479\u2013484. https:\/\/doi.org\/10.1002\/mds.29309","journal-title":"Mov Disord"},{"key":"2964_CR57","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00259-012-2100-5","volume":"39","author":"M Nocker","year":"2012","unstructured":"Nocker M, Seppi K, Donnemiller E et al (2012) Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]\u03b2-CIT SPECT. Eur J Nucl Med Mol Imaging 39:1012\u20131020. https:\/\/doi.org\/10.1007\/s00259-012-2100-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2964_CR58","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mds.27100","volume":"32","author":"E Ofori","year":"2017","unstructured":"Ofori E, Krismer F, Burciu RG et al (2017) Free water improves detection of changes in the substantia nigra in parkinsonism: a multisite study. Mov Disord 32:1457\u20131464. https:\/\/doi.org\/10.1002\/mds.27100","journal-title":"Mov Disord"},{"key":"2964_CR59","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","volume":"18","author":"S Orimo","year":"2012","unstructured":"Orimo S, Suzuki M, Inaba A, Mizusawa H (2012) 123I-MIBG myocardial scintigraphy for differentiating Parkinson\u2019s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord 18:494\u2013500. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.01.009","journal-title":"Parkinsonism Relat Disord"},{"key":"2964_CR60","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mds.28923","volume":"37","author":"J Palma","year":"2022","unstructured":"Palma J, Martinez J, Vernetti PM et al (2022) mTOR inhibition with sirolimus in multiple system atrophy: a randomized, double-blind, placebo-controlled futility trial and 1-year biomarker longitudinal analysis. Mov Disord 37:778\u2013789. https:\/\/doi.org\/10.1002\/mds.28923","journal-title":"Mov Disord"},{"key":"2964_CR61","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1111\/cns.13959","volume":"28","author":"H Pang","year":"2022","unstructured":"Pang H, Yu Z, Yu H et al (2022) Multimodal striatal neuromarkers in distinguishing parkinsonian variant of multiple system atrophy from idiopathic Parkinson\u2019s disease. CNS Neurosci Ther 28:2172\u20132182. https:\/\/doi.org\/10.1111\/cns.13959","journal-title":"CNS Neurosci Ther"},{"key":"2964_CR62","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/mds.29195","volume":"37","author":"J Pasquini","year":"2022","unstructured":"Pasquini J, Firbank MJ, Ceravolo R et al (2022) Diffusion magnetic resonance imaging microstructural abnormalities in multiple system atrophy: a comprehensive review. Mov Disord 37:1963\u20131984. https:\/\/doi.org\/10.1002\/mds.29195","journal-title":"Mov Disord"},{"key":"2964_CR63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00415-025-12932-5","volume":"272","author":"J Pasquini","year":"2025","unstructured":"Pasquini J, Sigurdsson HP, Firbank M et al (2025) Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy. J Neurol 272:195. https:\/\/doi.org\/10.1007\/s00415-025-12932-5","journal-title":"J Neurol"},{"key":"2964_CR64","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/brain\/awl021","volume":"129","author":"DC Paviour","year":"2006","unstructured":"Paviour DC, Price SL, Jahanshahi M et al (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129:1040\u20131049. https:\/\/doi.org\/10.1093\/brain\/awl021","journal-title":"Brain"},{"key":"2964_CR65","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00415-006-0396-4","volume":"254","author":"DC Paviour","year":"2007","unstructured":"Paviour DC, Price SL, Lees AJ, Fox NC (2007) MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. J Neurol 254:478\u2013481. https:\/\/doi.org\/10.1007\/s00415-006-0396-4","journal-title":"J Neurol"},{"key":"2964_CR66","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/mds.23601","volume":"26","author":"MT Pellecchia","year":"2011","unstructured":"Pellecchia MT, Picillo M, Filla A et al (2011) Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord 26:1303\u20131309. https:\/\/doi.org\/10.1002\/mds.23601","journal-title":"Mov Disord"},{"key":"2964_CR67","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mdc3.13052","volume":"7","author":"MT Pellecchia","year":"2020","unstructured":"Pellecchia MT, Stankovic I, Fanciulli A et al (2020) Can autonomic testing and imaging contribute to the early diagnosis of multiple system atrophy? A systematic review and recommendations by the Movement Disorder Society Multiple System Atrophy Study Group. Mov Disord Clin Pract 7:750\u2013762. https:\/\/doi.org\/10.1002\/mdc3.13052","journal-title":"Mov Disord Clin Pract"},{"key":"2964_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mdc3.13354","volume":"9","author":"C Peralta","year":"2022","unstructured":"Peralta C, Strafella AP, van Eimeren T et al (2022) Pragmatic approach on neuroimaging techniques for the differential diagnosis of Parkinsonisms. Mov Disord Clin Pract 9:6\u201319. https:\/\/doi.org\/10.1002\/mdc3.13354","journal-title":"Mov Disord Clin Pract"},{"key":"2964_CR69","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/mds.27307","volume":"33","author":"P P\u00e9ran","year":"2018","unstructured":"P\u00e9ran P, Barbagallo G, Nemmi F et al (2018) MRI supervised and unsupervised classification of Parkinson\u2019s disease and multiple system atrophy. Mov Disord 33:600\u2013608. https:\/\/doi.org\/10.1002\/mds.27307","journal-title":"Mov Disord"},{"key":"2964_CR70","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/mds.25115","volume":"27","author":"IN Petrovic","year":"2012","unstructured":"Petrovic IN, Ling H, Asi Y et al (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27:1186\u20131190. https:\/\/doi.org\/10.1002\/mds.25115","journal-title":"Mov Disord"},{"key":"2964_CR71","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/brain\/awv361","volume":"139","author":"PJ Planetta","year":"2016","unstructured":"Planetta PJ, Ofori E, Pasternak O et al (2016) Free-water imaging in Parkinson\u2019s disease and atypical parkinsonism. Brain 139:495\u2013508. https:\/\/doi.org\/10.1093\/brain\/awv361","journal-title":"Brain"},{"key":"2964_CR72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s1474-4422(14)70288-1","volume":"14","author":"W Poewe","year":"2015","unstructured":"Poewe W, Seppi K, Fitzer-Attas CJ et al (2015) Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial. Lancet Neurol 14:145\u2013152. https:\/\/doi.org\/10.1016\/s1474-4422(14)70288-1","journal-title":"Lancet Neurol"},{"key":"2964_CR73","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Prim 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Prim"},{"key":"2964_CR74","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","volume":"8","author":"W Poewe","year":"2022","unstructured":"Poewe W, Stankovic I, Halliday G et al (2022) Multiple system atrophy. Nat Rev Dis Prim 8:56. https:\/\/doi.org\/10.1038\/s41572-022-00382-6","journal-title":"Nat Rev Dis Prim"},{"key":"2964_CR75","doi-asserted-by":"publisher","first-page":"21683","DOI":"10.1038\/s41598-021-01222-5","volume":"11","author":"S Ponticorvo","year":"2021","unstructured":"Ponticorvo S, Manara R, Russillo MC et al (2021) Magnetic resonance T1w\/T2w ratio and voxel-based morphometry in multiple system atrophy. Sci Rep 11:21683. https:\/\/doi.org\/10.1038\/s41598-021-01222-5","journal-title":"Sci Rep"},{"key":"2964_CR76","doi-asserted-by":"publisher","first-page":"1017311","DOI":"10.3389\/fneur.2022.1017311","volume":"13","author":"S Ponticorvo","year":"2022","unstructured":"Ponticorvo S, Manara R, Russillo MC et al (2022) Combined regional T1w\/T2w ratio and voxel-based morphometry in multiple system atrophy: a follow-up study. Front Neurol 13:1017311. https:\/\/doi.org\/10.3389\/fneur.2022.1017311","journal-title":"Front Neurol"},{"key":"2964_CR77","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1212\/wnl.0b013e318250d7fd","volume":"78","author":"KL Poston","year":"2012","unstructured":"Poston KL, Tang CC, Eckert T et al (2012) Network correlates of disease severity in multiple system atrophy. Neurology 78:1237\u20131244. https:\/\/doi.org\/10.1212\/wnl.0b013e318250d7fd","journal-title":"Neurology"},{"key":"2964_CR78","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1007\/s00330-023-09665-2","volume":"33","author":"A Rau","year":"2023","unstructured":"Rau A, Schr\u00f6ter N, Rijntjes M et al (2023) Deep learning segmentation results in precise delineation of the putamen in multiple system atrophy. Eur Radiol 33:7160\u20137167. https:\/\/doi.org\/10.1007\/s00330-023-09665-2","journal-title":"Eur Radiol"},{"key":"2964_CR79","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.parkreldis.2013.10.002","volume":"20","author":"W Reginold","year":"2014","unstructured":"Reginold W, Lang AE, Marras C et al (2014) Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord 20:222\u2013225. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.10.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"2964_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13101471","volume":"13","author":"JP Rissardo","year":"2023","unstructured":"Rissardo JP, Caprara ALF (2023) Cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphy in Parkinson\u2019s disease: a comprehensive review. Brain Sci 13(10):1471. https:\/\/doi.org\/10.3390\/brainsci13101471","journal-title":"Brain Sci"},{"key":"2964_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","volume":"6","author":"U Saeed","year":"2017","unstructured":"Saeed U, Compagnone J, Aviv RI et al (2017) Imaging biomarkers in Parkinson\u2019s disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener 6:8. https:\/\/doi.org\/10.1186\/s40035-017-0076-6","journal-title":"Transl Neurodegener"},{"key":"2964_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07188-0","author":"M Scheifele","year":"2025","unstructured":"Scheifele M, Gn\u00f6rich J, Schr\u00f6der E et al (2025) Feasibility of a single-day protocol for SPECT and PET assessment of dopamine transporter availability, cardiac innervation and metabolic patterns in patients with movement disorders. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-025-07188-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2964_CR83","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/mds.21505","volume":"22","author":"C Scherfler","year":"2007","unstructured":"Scherfler C, Schwarz J, Antonini A et al (2007) Role of DAT-SPECT in the diagnostic work up of Parkinsonism. Mov Disord 22:1229\u20131238. https:\/\/doi.org\/10.1002\/mds.21505","journal-title":"Mov Disord"},{"key":"2964_CR84","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1212\/wnl.0000000000002518","volume":"86","author":"C Scherfler","year":"2016","unstructured":"Scherfler C, G\u00f6bel G, M\u00fcller C et al (2016) Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism. Neurology 86:1242\u20131249. https:\/\/doi.org\/10.1212\/wnl.0000000000002518","journal-title":"Neurology"},{"key":"2964_CR85","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1007\/s00259-021-05302-6","volume":"48","author":"KA Schindlbeck","year":"2021","unstructured":"Schindlbeck KA, Gupta DK, Tang CC et al (2021) Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism. Eur J Nucl Med Mol Imaging 48:3522\u20133529. https:\/\/doi.org\/10.1007\/s00259-021-05302-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2964_CR86","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41531-022-00392-x","volume":"8","author":"N Schr\u00f6ter","year":"2022","unstructured":"Schr\u00f6ter N, Blazhenets G, Frings L et al (2022) Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes. Npj Park\u2019s Dis 8:123. https:\/\/doi.org\/10.1038\/s41531-022-00392-x","journal-title":"Npj Park\u2019s Dis"},{"key":"2964_CR87","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00062-023-01377-w","volume":"34","author":"N Schr\u00f6ter","year":"2024","unstructured":"Schr\u00f6ter N, Arnold PG, Hosp JA et al (2024) Complemental value of microstructural and macrostructural MRI in the discrimination of neurodegenerative Parkinson syndromes. Clin Neuroradiol 34:411\u2013420. https:\/\/doi.org\/10.1007\/s00062-023-01377-w","journal-title":"Clin Neuroradiol"},{"key":"2964_CR88","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1212\/01.wnl.0000049911.91657.9d","volume":"60","author":"K Seppi","year":"2003","unstructured":"Seppi K, Schocke MFH, Esterhammer R et al (2003) Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60:922\u2013927. https:\/\/doi.org\/10.1212\/01.wnl.0000049911.91657.9d","journal-title":"Neurology"},{"key":"2964_CR89","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuroimage.2005.12.006","volume":"31","author":"K Seppi","year":"2006","unstructured":"Seppi K, Schocke MFH, Mair KJ et al (2006) Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 31:240\u2013245. https:\/\/doi.org\/10.1016\/j.neuroimage.2005.12.006","journal-title":"Neuroimage"},{"key":"2964_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.06.006","volume":"42","author":"A Shafieesabet","year":"2017","unstructured":"Shafieesabet A, Fereshtehnejad S-M, Shafieesabet A et al (2017) Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson\u2019s disease: a meta-analysis. Parkinsonism Relat Disord 42:1\u201311. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.06.006","journal-title":"Parkinsonism Relat Disord"},{"key":"2964_CR91","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s00330-018-5874-4","volume":"29","author":"A Shah","year":"2019","unstructured":"Shah A, Prasad S, Rastogi B et al (2019) Altered structural connectivity of the motor subnetwork in multiple system atrophy with cerebellar features. Eur Radiol 29:2783\u20132791. https:\/\/doi.org\/10.1007\/s00330-018-5874-4","journal-title":"Eur Radiol"},{"key":"2964_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102416","volume":"28","author":"B Shen","year":"2020","unstructured":"Shen B, Wei S, Ge J et al (2020) Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts. NeuroImage Clin 28:102416. https:\/\/doi.org\/10.1016\/j.nicl.2020.102416","journal-title":"NeuroImage Clin"},{"key":"2964_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-02007-5","volume":"20","author":"RM Sim\u00f5es","year":"2020","unstructured":"Sim\u00f5es RM, Caldas AC, Grilo J et al (2020) A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy. BMC Neurol 20:432. https:\/\/doi.org\/10.1186\/s12883-020-02007-5","journal-title":"BMC Neurol"},{"key":"2964_CR94","doi-asserted-by":"publisher","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","volume":"14","author":"R Smith","year":"2023","unstructured":"Smith R, Capotosti F, Schain M et al (2023) The \u03b1-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases. Nat Commun 14:6750. https:\/\/doi.org\/10.1038\/s41467-023-42305-3","journal-title":"Nat Commun"},{"key":"2964_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s1474-4422(10)70002-8","volume":"9","author":"CC Tang","year":"2010","unstructured":"Tang CC, Poston KL, Eckert T et al (2010) Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 9:149\u2013158. https:\/\/doi.org\/10.1016\/s1474-4422(10)70002-8","journal-title":"Lancet Neurol"},{"key":"2964_CR96","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2967\/jnumed.115.161992","volume":"57","author":"M Tripathi","year":"2016","unstructured":"Tripathi M, Tang CC, Feigin A et al (2016) Automated differential diagnosis of early Parkinsonism using metabolic brain networks: a validation study. J Nucl Med 57:60\u201366. https:\/\/doi.org\/10.2967\/jnumed.115.161992","journal-title":"J Nucl Med"},{"key":"2964_CR97","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.0112","author":"DE Vaillancourt","year":"2025","unstructured":"Vaillancourt DE, Barmpoutis A, Wu SS et al (2025) Automated imaging differentiation for parkinsonism. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0112","journal-title":"JAMA Neurol"},{"key":"2964_CR98","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2022.08.028","volume":"103","author":"P Vemuri","year":"2022","unstructured":"Vemuri P, Castillo AM, Thostenson KB et al (2022) Imaging biomarkers for early multiple system atrophy. Parkinsonism Relat Disord 103:60\u201368. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.08.028","journal-title":"Parkinsonism Relat Disord"},{"key":"2964_CR99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1212\/wnl.60.1.74","volume":"60","author":"U Walter","year":"2003","unstructured":"Walter U, Niehaus L, Probst T et al (2003) Brain parenchyma sonography discriminates Parkinson\u2019s disease and atypical parkinsonian syndromes. Neurology 60:74\u201377. https:\/\/doi.org\/10.1212\/wnl.60.1.74","journal-title":"Neurology"},{"key":"2964_CR100","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40035-023-00370-0","volume":"12","author":"L Wan","year":"2023","unstructured":"Wan L, Zhu S, Chen Z et al (2023) Multidimensional biomarkers for multiple system atrophy: an update and future directions. Transl Neurodegener 12:38. https:\/\/doi.org\/10.1186\/s40035-023-00370-0","journal-title":"Transl Neurodegener"},{"key":"2964_CR101","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3174\/ajnr.a2765","volume":"33","author":"Y Wang","year":"2012","unstructured":"Wang Y, Butros SR, Shuai X et al (2012) Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. Am J Neuroradiol 33:266\u2013273. https:\/\/doi.org\/10.3174\/ajnr.a2765","journal-title":"Am J Neuroradiol"},{"key":"2964_CR102","doi-asserted-by":"publisher","first-page":"1427991","DOI":"10.3389\/fnagi.2024.1427991","volume":"16","author":"S Wang","year":"2024","unstructured":"Wang S, Xiao Y, Hou Y et al (2024) Comparison of spontaneous brain activity in distinguishing parkinsonian variant of multiple system atrophy from Parkinson\u2019s disease at an early stage. Front Aging Neurosci 16:1427991. https:\/\/doi.org\/10.3389\/fnagi.2024.1427991","journal-title":"Front Aging Neurosci"},{"key":"2964_CR103","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/s1474-4422(12)70327-7","volume":"12","author":"GK Wenning","year":"2013","unstructured":"Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12:264\u2013274. https:\/\/doi.org\/10.1016\/s1474-4422(12)70327-7","journal-title":"Lancet Neurol"},{"key":"2964_CR104","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37:1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"2964_CR105","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf030","author":"JA Wiseman","year":"2025","unstructured":"Wiseman JA, Halliday GM, Dieriks BV (2025) Neuronal \u03b1-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy. Brain. https:\/\/doi.org\/10.1093\/brain\/awaf030","journal-title":"Brain"},{"key":"2964_CR106","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.irn.2018.09.001","volume":"142","author":"Z Xu","year":"2018","unstructured":"Xu Z, Arbizu J, Pavese N (2018) Chapter one PET molecular imaging in atypical parkinsonism. Int Rev Neurobiol 142:3\u201336. https:\/\/doi.org\/10.1016\/bs.irn.2018.09.001","journal-title":"Int Rev Neurobiol"},{"key":"2964_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106549","volume":"198","author":"S Yan","year":"2024","unstructured":"Yan S, Lu J, Duan B et al (2024) Quantitative susceptibility mapping of multiple system atrophy and Parkinson\u2019s disease correlates with neurotransmitter reference maps. Neurobiol Dis 198:106549. https:\/\/doi.org\/10.1016\/j.nbd.2024.106549","journal-title":"Neurobiol Dis"},{"key":"2964_CR108","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s12311-020-01144-4","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ji S, Ren S et al (2020) Cerebellar atrophy in multiple system atrophy (cerebellar type) and its implication for network connectivity. Cerebellum 19:636\u2013644. https:\/\/doi.org\/10.1007\/s12311-020-01144-4","journal-title":"Cerebellum"},{"key":"2964_CR109","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1007\/s00259-022-05804-x","volume":"49","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wu P, Wu J et al (2022) Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning. Eur J Nucl Med Mol Imaging 49:2798\u20132811. https:\/\/doi.org\/10.1007\/s00259-022-05804-x","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02964-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:51:22Z","timestamp":1779882682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02964-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2964"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02964-6","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}